Estepan Ian Michael, COO of Sarepta Therapeutics ($SRPT), sold shares once on the open market in the last year, totaling about $294 thousand. His most recent sale occurred on December 16, 2025. Among 11,678 insiders, his sales rank 7,601st by value, well below the $8.6 million average over 6.37 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | F | Common Stock | 1097 | $17.03 | 201,983.0000 | 100,237,000 | 0.54% | 0.00% |
| March 9, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | F | Common Stock | 583 | $16.95 | 203,080.0000 | 100,237,000 | 0.29% | 0.00% |
| March 9, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | F | Common Stock | 1036 | $16.95 | 203,663.0000 | 100,237,000 | 0.51% | 0.00% |
| March 1, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | M | Performance Stock Units | 8125 | $0.00 | 0.0000 | 100,237,000 | 100.00% | 0.01% |
| March 2, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | F | Common Stock | 3301 | $16.20 | 205,574.0000 | 100,237,000 | 1.58% | 0.00% |
| March 1, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | M | Common Stock | 8125 | $0.00 | 208,875.0000 | 100,237,000 | 4.05% | 0.01% |
| March 2, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | F | Common Stock | 875 | $16.20 | 204,699.0000 | 100,237,000 | 0.43% | 0.00% |
| Feb. 26, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | M | Stock Option (right to buy) | 2069 | $0.00 | 0.0000 | 100,237,000 | 100.00% | 0.00% |
| Feb. 26, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | M | Common Stock | 2069 | $13.71 | 195,369.0000 | 100,237,000 | 1.07% | 0.00% |
| Feb. 26, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | M | Stock Option (right to buy) | 5381 | $0.00 | 0.0000 | 100,237,000 | 100.00% | 0.01% |
| Feb. 26, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | M | Common Stock | 5381 | $13.71 | 200,750.0000 | 100,237,000 | 2.75% | 0.01% |
| Feb. 25, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | A | Performance Stock Units | 1875 | $0.00 | 8,125.0000 | 100,237,000 | 30.00% | 0.00% |
| Dec. 16, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | S | Common Stock | 13187 | $22.31 | 193,300.0000 | 100,237,000 | 6.39% | 0.01% |
| Sept. 3, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | A | Common Stock | 50000 | $0.00 | 206,487.0000 | 107,875,000 | 31.95% | 0.05% |
| Sept. 3, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | A | Common Stock | 93875 | $0.00 | 156,487.0000 | 107,875,000 | 149.93% | 0.09% |
| Aug. 5, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Operating Officer | A | Performance Stock Units | 6250 | $0.00 | 6,250.0000 | 107,875,000 | 9999.99% | 0.01% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | A | Stock Options (right to buy) | 16644 | $0.00 | 16,644.0000 | 107,875,000 | 9999.99% | 0.02% |
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Common Stock | 5500 | $0.00 | 58,277.0000 | 107,875,000 | 10.42% | 0.01% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 1051 | $100.13 | 57,226.0000 | 107,875,000 | 1.80% | 0.00% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 2890 | $100.13 | 54,336.0000 | 107,875,000 | 5.05% | 0.00% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | A | Common Stock | 8276 | $0.00 | 62,612.0000 | 107,875,000 | 15.23% | 0.01% |
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Performance Stock Units | 5500 | $0.00 | 0.0000 | 107,875,000 | 100.00% | 0.01% |
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 9094 | $103.70 | 52,777.0000 | 107,875,000 | 14.70% | 0.01% |
| March 6, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Common Stock | 17500 | $0.00 | 62,456.0000 | 107,875,000 | 38.93% | 0.02% |
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 585 | $103.70 | 61,871.0000 | 107,875,000 | 0.94% | 0.00% |
| March 6, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Performance Stock Units | 17500 | $0.00 | 0.0000 | 107,875,000 | 100.00% | 0.02% |
| March 4, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 1370 | $101.34 | 44,956.0000 | 107,875,000 | 2.96% | 0.00% |
| March 3, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 557 | $103.77 | 46,326.0000 | 107,875,000 | 1.19% | 0.00% |
| Feb. 11, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | A | Performance Restricted Stock Units | 3500 | $0.00 | 17,500.0000 | 107,875,000 | 25.00% | 0.00% |
| Jan. 29, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Stock Option (right to buy) | 14267 | $0.00 | 0.0000 | 107,875,000 | 100.00% | 0.01% |
| Jan. 29, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Common Stock | 14267 | $12.00 | 47,963.0000 | 107,875,000 | 42.34% | 0.01% |
| Jan. 29, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Common Stock | 1533 | $12.00 | 49,496.0000 | 107,875,000 | 3.20% | 0.00% |
| Jan. 29, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 2613 | $117.51 | 46,883.0000 | 107,875,000 | 5.28% | 0.00% |
| Jan. 29, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Stock Option (right to buy) | 1533 | $0.00 | 0.0000 | 107,875,000 | 100.00% | 0.00% |
| Dec. 27, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | G | Common Stock | 250 | $0.00 | 33,696.0000 | 100,448,000 | 0.74% | 0.00% |
| Aug. 30, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | S | Common Stock | 5985 | $137.36 | 33,946.0000 | 92,398,000 | 14.99% | 0.01% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Common Stock | 6250 | $0.00 | 42,414.0000 | 92,398,000 | 17.28% | 0.01% |
| June 24, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 2483 | $164.64 | 39,931.0000 | 92,398,000 | 5.85% | 0.00% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | M | Performance Stock Units | 6250 | $0.00 | 0.0000 | 92,398,000 | 100.00% | 0.01% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | A | Performance Stock Units | 6250 | $0.00 | 6,250.0000 | 92,398,000 | 9999.99% | 0.01% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | A | Performance Stock Units | 5500 | $0.00 | 5,500.0000 | 92,398,000 | 9999.99% | 0.01% |
| March 7, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 526 | $120.49 | 37,199.0000 | 92,398,000 | 1.39% | 0.00% |
| March 8, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 1035 | $123.14 | 36,164.0000 | 92,398,000 | 2.78% | 0.00% |
| March 4, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 1389 | $125.32 | 37,725.0000 | 92,398,000 | 3.55% | 0.00% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | A | Common Stock | 6000 | $0.00 | 40,314.0000 | 92,398,000 | 17.49% | 0.01% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | F | Common Stock | 365 | $126.19 | 34,314.0000 | 92,398,000 | 1.05% | 0.00% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 92,398,000 | 50.00% | 0.01% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Estepan Ian Michael | Chief Financial Officer | S | Common Stock | 1200 | $128.30 | 39,114.0000 | 92,398,000 | 2.98% | 0.00% |